Upper GI 2017

OE-5 Study

1.00

Median survival (95% CI) CF 2.02 (1.80, 2.38) ys ECX 2.15 (1.93, 2.53) ys HR 0.92

CF

ECX

0.75

0.50

(0.79, 1.08)

0.25

P ro p o r t io n s u rv iv in g

P- value

0.8582

3-year survival (95% CI) CF 39% (35%, 44%) ECX 42% (37%, 46%)

0.00

0

1

2

3

4

5

6

7

8

Time from randomisation (Years)

446 343 229 172 124 91 70 45 23 ECX 451 345 227 167 121 71 46 21 13 CF At risk

Alderson D et al. ASCO 2015; #4002

© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick